<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - Sangamo BioSciences</title>
    <link>http://www.newstin.co.uk/uk/SANGAMO_BIOSCIENCES</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Sangamo BioSciences - News</title>
      <link>http://www.newstin.co.uk/uk/SANGAMO_BIOSCIENCES</link>
      <description>You are currently using FREE feeds from Newstin. You will get more data and services with Newstin Pro RSS licensed subscription.&lt;br/&gt;Newstin Pro RSS provides aggregated and categorized news content covering 1.25 Million news categories from 160.000 online sources in the format that can be easily integrated into environment or software of your choice. &lt;a href="http://corp.newstin.com/static.a?tpl=corp_rss"&gt;Read more about Newstin Pro RSS&lt;/a&gt; or &lt;a href="http://corp.newstin.com/files/corp/newstin_prorss.pdf"&gt;download the product presentation now&lt;/a&gt;.</description>
      <pubDate>Fri, 27 Nov 2009 05:40:58 GMT</pubDate>
      <guid>http://www.newstin.co.uk/uk/SANGAMO_BIOSCIENCES</guid>
      <dc:date>2009-11-27T05:40:58Z</dc:date>
    </item>
    <item>
      <title>Ohr Pharmaceutical to develop OHR/AVR118 for cachexia treatment</title>
      <link />
      <description />
      <pubDate>Tue, 24 Nov 2009 14:37:55 GMT</pubDate>
      <guid />
      <dc:date>2009-11-24T14:37:55Z</dc:date>
    </item>
    <item>
      <title>Research and Markets: Laboratory Chemical Reagents - A Global Market Review</title>
      <link />
      <description />
      <pubDate>Mon, 23 Nov 2009 15:59:03 GMT</pubDate>
      <guid />
      <dc:date>2009-11-23T15:59:03Z</dc:date>
    </item>
    <item>
      <title>Reportlinker Adds Biotechnology Reagents - A Global Market Perspective</title>
      <link />
      <description />
      <pubDate>Thu, 19 Nov 2009 19:55:54 GMT</pubDate>
      <guid />
      <dc:date>2009-11-19T19:55:54Z</dc:date>
    </item>
    <item>
      <title>Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS</title>
      <link />
      <description />
      <pubDate>Wed, 18 Nov 2009 20:31:00 GMT</pubDate>
      <guid />
      <dc:date>2009-11-18T20:31:00Z</dc:date>
    </item>
    <item>
      <title>Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS</title>
      <link />
      <description />
      <pubDate>Thu, 19 Nov 2009 02:54:00 GMT</pubDate>
      <guid />
      <dc:date>2009-11-19T02:54:00Z</dc:date>
    </item>
    <item>
      <title>Sangamo BioSciences, Inc. - Pharmaceuticals &amp; Healthcare - Deals and Alliances Profile - new...</title>
      <link />
      <description />
      <pubDate>Tue, 10 Nov 2009 00:25:02 GMT</pubDate>
      <guid />
      <dc:date>2009-11-10T00:25:02Z</dc:date>
    </item>
    <item>
      <title>WallstreetStockReview.com on Environmental Protection</title>
      <link />
      <description />
      <pubDate>Sun, 08 Nov 2009 20:01:27 GMT</pubDate>
      <guid />
      <dc:date>2009-11-08T20:01:27Z</dc:date>
    </item>
    <item>
      <title>Sangamo 3Q loss narrows on payments, lower costs</title>
      <link />
      <description />
      <pubDate>Thu, 05 Nov 2009 15:36:10 GMT</pubDate>
      <guid />
      <dc:date>2009-11-05T15:36:10Z</dc:date>
    </item>
    <item>
      <title>Sangamo BioSciences Reports Third Quarter 2009 Financial Results</title>
      <link />
      <description />
      <pubDate>Wed, 04 Nov 2009 22:25:47 GMT</pubDate>
      <guid />
      <dc:date>2009-11-04T22:25:47Z</dc:date>
    </item>
  </channel>
</rss>

